GpharmaBio
RESEARCH PEPTIDE LAB
part of GBAGROUPCERTIFICATE OF ANALYSIS
GPB-4594
- PRODUCT
- Tirzepatide
- FILL
- 10 mg / 3 mL vial · box of 10
- SYNTHESISED
- 19 Apr 2026
- RELEASED
- 27 Apr 2026
- RETEST
- Apr 2028
IDENTITY
- CAS NUMBER
- 2023788-19-2
- MOLECULAR FORMULA
- C₂₂₅H₃₄₈N₄₈O₆₈
- MOLECULAR WEIGHT
- 4813.53 g/mol
98.8%
Measured, this lot
Release specification ≥ 98.0%
Red rule marks the house release limit. This lot sits 0.8 points above it. Area percent cannot see anything without a chromophore at 214 nm, which is why moisture, counterion and net peptide content are reported separately below.
| TEST | RESULT, THIS LOT |
|---|---|
| RP-HPLC purity | 98.8% area @ 214 nm |
| Identity (ESI-MS) | 4813.9 observed, deconvoluted |
| Identity (co-injection) | Single peak vs. reference |
| Net peptide content | 78.2% |
| Water (Karl Fischer) | 4.1% |
| Bacterial endotoxin | < 0.25 EU/mg (LAL) |
X2G4-248P